Drugmakers unveil cancer drug data at the ASCO annual meeting, while Amazon Pharmacy announces new features for caregivers, Medicare patients.…
…
…
NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat die Einstufung für Pfizer anlässlich der Asco-Krebsforschertagung mit einem Kursziel von…
NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat die Einstufung für Pfizer anlässlich der Asco-Krebsforschertagung mit einem Kursziel von…
Dublin, June 02, 2025 (GLOBE NEWSWIRE) -- The "Addiction Disorders Drugs Market by Indication, Product Type, Route of…
The past three years have been challenging for Pfizer (NYSE: PFE). Revenue and earnings have moved in the wrong direction,…
NEW HAVEN, Conn. and NEW YORK, May 31, 2025 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN) and Pfizer Inc. (NYSE:…
Pfizer (PFE) reported earnings 30 days ago. Whats next for the stock? We take a look at earnings estimates for…
HAMBURG (dpa-AFX Analyser) - Die Privatbank Berenberg hat das Kursziel für Pfizer von 28 auf 25 US-Dollar gesenkt und die…
HAMBURG (dpa-AFX Analyser) - Die Privatbank Berenberg hat das Kursziel für Pfizer von 28 auf 25 US-Dollar gesenkt und die…
…
Pfizer (NYSE: PFE) made a fortune thanks to its work in the COVID-19 market. In 2022, it became the first…
Pfizer (PFE) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware…
The Qatar Dietary Supplements Market is set to grow from USD 48.19 Million in 2024 to USD 70.48 Million by…
Bispecific anti-PD1/VEGF remains one of the hottest topics in the oncology field. Click here for a detailed analysis.…
Pfizer has taken its lumps lately. Its time to wonder whether the stock can make a comeback.…
Pfizers (NYSE: PFE) management team is confident in its 2025 opportunities.
Where to invest $1,000 right now? Our analyst team just…
…
NEW YORK (dpa-AFX Analyser) - Das Analysehaus Jefferies hat das Kursziel für Pfizer angesichts der Lizenzierung eines Krebsmedikaments aus China…
NEW YORK (dpa-AFX Analyser) - Das Analysehaus Jefferies hat das Kursziel für Pfizer angesichts der Lizenzierung eines Krebsmedikaments aus China…
Pfizer, Coca-Cola and The Walt Disney are part of the Zacks top Analyst Blog.…
Though there are plenty of dividend stocks on the market, they arent all created equal. Consider that the average dividend…
Resilient and growing. Those two descriptions definitely apply to the healthcare sector. People need healthcare products and services regardless of…
Though the new FDA rules limit access to COVID-19 booster vaccines, the commitment to high-risk groups lifts Moderna, Pfizer and…
Frankfurt (www.aktiencheck.de) - Pfizer-Aktienanalyse von XTB:
Die Experten von XTB nehmen die Aktie von Pfizer Inc. (ISIN: US7170811035, WKN: 852009, Ticker-Symbol:…
NEW YORK (dpa-AFX Analyser) - Das Analysehaus Jefferies hat Biontech auf "Buy" mit einem Kursziel von 149 US-Dollar belassen. Die…
…
Pfizer inks Experimental Drug Licensing Deal With China-based company 3SBio.…
Pfizer Inc (NYSE:PFE, ETR:PFE) has agreed a licensing deal worth up to $6 billion with Chinese biopharmaceutical group 3SBio to develop…
If you see a stock that pays 6% in dividends, you might assume its too risky -- but thats not…
Bad Marienberg (www.aktiencheck.de) -
Pfizer Aktienanalyse: 3SBio-Deal, Q1 2025 Zahlen &
Analystenkommentare
Pfizer Aktienanalyse: Milliarden-Deal mit 3SBio & solide…
Der Pharma-Riese Pfizer stärkt erneut sein Entwicklungsportfolio. Die US-Amerikaner sind dieses Mal in China fündig geworden und haben einen milliardenschweren…
Pfizer has signed a licensing agreement worth up to $6 billion with Chinese pharmaceutical products developer 3SBio Inc for the…
Pfizer signs up to $6 billion licensing deal with China’s 3SBio for cancer drug…
…
…
US House panel seeks information from Pfizer over alleged COVID vaccine delay…
StoneCo, Centene, CVS Health and Pfizer have been highlighted in this Screen of The Week article.…
LUXEMBURG (dpa-AFX) - Die "New York Times" hat im Rechtsstreit um die Herausgabe von SMS von EU-Kommissionspräsidentin Ursula von der…
LUXEMBURG (dpa-AFX) - Die "New York Times" hat im Rechtsstreit um die Herausgabe von SMS von…
LUXEMBURG (dpa-AFX) - Im Rechtsstreit um Textnachrichten an einen Pharma-Konzernchef hat EU-Kommissionspräsidentin Ursula von der Leyen…
LUXEMBURG (dpa-AFX) - Das Gericht der EU urteilt am Mittwoch zur Herausgabe der SMS-Nachrichten von EU-Kommissionspräsidentin Ursula von der Leyen…
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to…
J&J, Eli Lilly, Pfizer, Merck, Amgen are included in this Analyst Blog.…
The President is scheduled to sign an Executive Order on Monday to upend the entire pharmaceutical industry.…
Income investors have liked Pfizer (NYSE: PFE) for years. However, the big drugmakers exceptionally juicy dividend these days has made…
…
PCB, G-III Apparel, Gibraltar, Pfizer and Pampa Energia have been highlighted in this Screen of The Week article.…
Good things could be on the horizon when a stock surpasses the 20-day simple moving average. How should investors react?…